Subcutaneous mastectomy and immediate reconstruction for prevention of breast cancer for high-risk patients

作者: Roy H. Ashikari , Andrew Y. Ashikari , Pond R. Kelemen , C. Andrew Salzberg

DOI: 10.1007/S12282-008-0059-7

关键词: OncologyLung cancerCancerSubcutaneous MastectomyProphylactic MastectomyTamoxifenMedicineBreast cancerInframammary foldInternal medicineRaloxifene

摘要: Breast cancer is the most common malignant tumor among females in USA, with one out of eight American developing breast their lifetimes. The latest studies [1] show that 212,920 new cases invasive developed 2006, which 2.5 times more than incidence lung cancer, and 40,970 will die from this disease each year. Therefore, awareness an important health issue, women beginning to assess risk either informally or instruments such as GAIL model [2]. availability genetic testing for BRCA-1 BRCA-2 has revealed many who are at significantly increased risk. Many aggressive surveillance programs have been using advanced MRI ultrasound, reductions 50% proven chemoprevention strategies tamoxifen raloxifene. However, starting seriously consider prophylactic mastectomy near-total reduction At our institution, we a procedure subcutaneous via inframammary incision spares nipple combined immediate silicone implant reconstruction assistance Alloderm®. In article describe some issues surrounding its implementation experience.

参考文章(15)
V R Grann, K S Panageas, W Whang, K H Antman, A I Neugut, Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients. Journal of Clinical Oncology. ,vol. 16, pp. 979- 985 ,(1998) , 10.1200/JCO.1998.16.3.979
Shannon K. McDonnell, Daniel J. Schaid, Jeffrey L. Myers, Clive S. Grant, John H. Donohue, John E. Woods, Marlene H. Frost, Joanne L. Johnson, Diana L. Sitta, Jeffrey M. Slezak, Thomas B. Crotty, Robert B. Jenkins, Thomas A. Sellers, Lynn C. Hartmann, Efficacy of Contralateral Prophylactic Mastectomy in Women With a Personal and Family History of Breast Cancer Journal of Clinical Oncology. ,vol. 19, pp. 3938- 3943 ,(2001) , 10.1200/JCO.2001.19.19.3938
A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, C. Smigal, M. J. Thun, Cancer statistics, 2006. CA: A Cancer Journal for Clinicians. ,vol. 56, pp. 106- 130 ,(2006) , 10.3322/CANJCLIN.56.2.106
Deborah Schrag, Karen M. Kuntz, Judy E. Garber, Jane C. Weeks, Decision analysis - Effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations The New England Journal of Medicine. ,vol. 336, pp. 1465- 1471 ,(1997) , 10.1056/NEJM199705153362022
C.M.E. Contant, M.B.E. Menke-Pluijmers, C. Seynaeve, E.J. Meijers-Heijboer, J.G.M. Klijn, L.C. Verhoog, R. Tjong Joe Wai, A.M.M. Eggermont, A.N. van Geel, Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation. Ejso. ,vol. 28, pp. 627- 632 ,(2002) , 10.1053/EJSO.2002.1279
Hanne Meijers-Heijboer, Bert van Geel, Wim L.J. van Putten, Sonja C. Henzen-Logmans, Caroline Seynaeve, Marian B.E. Menke-Pluymers, Carina C.M. Bartels, Leon C. Verhoog, Ans M.W. van den Ouweland, Martinus F. Niermeijer, Cecile T.M. Brekelmans, Jan G.M. Klijn, Breast Cancer After Prophylactic Bilateral Mastectomy in Women With a BRCA1 or BRCA2 Mutation The New England Journal of Medicine. ,vol. 345, pp. 159- 164 ,(2001) , 10.1056/NEJM200107193450301
Vincent R. Pennisi, Angelo Capozzi, Subcutaneous mastectomy: an interim report on 1,244 patients Annals of Plastic Surgery. ,vol. 12, pp. 340- 345 ,(1984) , 10.1097/00000637-198404000-00006
BROMLEY S. FREEMAN, Subcutaneous mastectomy for benign breast lesions with immediate or delayed prosthetic replacement. Plastic and Reconstructive Surgery. ,vol. 30, pp. 676- 682 ,(1962) , 10.1097/00006534-196212000-00008
Victor G Vogel, Joseph P Costantino, D Lawrence Wickerham, Walter M Cronin, Reena S Cecchini, James N Atkins, Therese B Bevers, Louis Fehrenbacher, Eduardo R Pajon, James L Wade, André Robidoux, Richard G Margolese, Joan James, Scott M Lippman, Carolyn D Runowicz, Patricia A Ganz, Steven E Reis, Worta McCaskill-Stevens, Leslie G Ford, V Craig Jordan, Norman Wolmark, National Surgical Adjuvant Breast and Bowel Project, None, Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease OutcomesThe NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial JAMA. ,vol. 295, pp. 2727- 2741 ,(2006) , 10.1001/JAMA.295.23.JOC60074